NOI_CDRH-2023-117782.PDF
Published: 09/11/2023
Description
Page 1 of 1 Notice of Intent to Sole Source Date: September 11, 2023 Subject: Contrast Anthropomorphic Breast Phantoms The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source award to Phantomx GMBH. The Govern...
